Rob Dillard

DocwireNews

Deaths from <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/study-cancer-survivors-have-higher-rates-of-prescription-opioid-use-but-similar-rates-of-opioid-misuse-compared-to-individuals-without-cancer/">cancer</a> accounted for more than 4 million potential years of life lost (PYLL) in 2017, according to a study published in Cancer Epidemiology, Biomarkers &amp; Prevention.Researchers used national mortality data from the U.S. National Center for Health Statistics, coupled with a commonly used definition of PYLL as the number of years lost prior to age 75, to quantify how many years of life were prematurely lost.According to the results, PYLL mirrored overall U.S. cancer mortality trends. For example, lung cancer, the cancer type that causes the largest number of deaths, accounted for approximately 24.3 percent of U.S. cancer deaths and 20.8 percent of PYLL. Colon/rectum cancer accounted for 8.8 percent of deaths and 9.6 percent of PYLL. Pancreatic cancer accounted for 7.3 percent of deaths and 6.6 percent of PYLL, while breast cancer accounted for 7.1 percent of deaths and 9.4 percent of PYLL.One exception to this pattern was prostate cancer, which causes about 5.1 percent of U.S. cancer deaths but only 2 percent of PYLL. &ldquo;Many of the deaths caused by this cancer occurred at older ages, resulting in fewer PYLL,&rdquo; said Minkyo Song, MD, PhD, a research fellow at the National Cancer institute via a <a href="https://www.eurekalert.org/pub_releases/2020-11/aafc-cdr111120.php">press release.</a><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<a href="https://twitter.com/hashtag/Cancer?src=hash&amp;ref_src=twsrc%5Etfw">#Cancer</a> deaths resulted in more than 4 million potential years of life lost in 2017 <a href="https://t.co/D5Y0KJPN4R">https://t.co/D5Y0KJPN4R</a>
&mdash; Medical Xpress (@physorg_health) <a href="https://twitter.com/physorg_health/status/1327171009686941696?ref_src=twsrc%5Etfw">November 13, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&ldquo;PYLL is a useful &lsquo;complementary measure&rsquo; to cancer mortality rates. Together, they provide a more detailed picture of the social and economic toll of cancer. PYLL can be used to estimate the impact of cancer death in younger populations. This metric highlights the enormous loss of life due to certain cancers that occur at younger ages, even if they occur infrequently.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Cancer deaths resulted in more than 4 million potential years of life lost in the U.S. in 2017. While overall cancer mortality has gone down, the potential number of years of lost life has remained stable due to the growing U.S. population <a href="https://twitter.com/hashtag/Radiology?src=hash&amp;ref_src=twsrc%5Etfw">#Radiology</a>
&mdash; ISR Radiology (@ISR_Radiology) <a href="https://twitter.com/ISR_Radiology/status/1327242776954728448?ref_src=twsrc%5Etfw">November 13, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&nbsp;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Cancer Resulted in More than 4 Million Potential Years of Life Lost in 2017, Study Finds

Oncology

Deaths from cancer accounted for more than 4 million potential years of life lost (PYLL) in 2017, according to a study published in Cancer Epidemiology, Biomarkers &amp; ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe